FDA Drug Application (020120) for ALLERNAZE by LUPIN ATLANTIS

Back to FDA Applications sponsored by LUPIN ATLANTIS

Application Number020120
Product Number001
FormSPRAY, METERED;NASAL
Dosage0.05MG/SPRAY
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameALLERNAZE
Active IngredientTRIAMCINOLONE ACETONIDE

Active IngredientCount
List of drugs with Active Ingredient TRIAMCINOLONE ACETONIDE33


Back to FDA Applications sponsored by LUPIN ATLANTIS